National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Meeting, 52076-52077 [E6-14556]
Download as PDF
52076
Federal Register / Vol. 71, No. 170 / Friday, September 1, 2006 / Notices
Board of Governors of the Federal Reserve
System, August 28, 2006.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E6–14505 Filed 8–31–06; 8:45 am]
Board of Governors of the Federal Reserve
System, August 28, 2006.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E6–14504 Filed 8–31–06; 8:45 am]
BILLING CODE 6210–01–S
BILLING CODE 6210–01–S
FEDERAL RESERVE SYSTEM
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
sroberts on PROD1PC70 with NOTICES
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR Part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than September 25,
2006.
A. Federal Reserve Bank of
Richmond (A. Linwood Gill, III, Vice
President) 701 East Byrd Street,
Richmond, Virginia 23261-4528:
1. First Charter Corporation,
Charlotte, North Carolina; to acquire 100
percent of the voting shares of GBC
Bancorp, Inc., and thereby indirectly
acquire Gwinnett Banking Company,
both of Lawrenceville, Georgia.
VerDate Aug<31>2005
16:21 Aug 31, 2006
Jkt 208001
Office of the National Coordinator;
American Health Information
Community Biosurveillance Data
Steering Group Meeting
ACTION:
Announcement of meeting.
SUMMARY: This notice announces the
fifth meeting of the American Health
Information Community Biosurveillance
Data Steering Group in accordance with
the Federal Advisory Committee Act
(Pub. L. 92–463, 5 U.S.C., App.).
DATES: September 5, 2006, 2 to 4 p.m.
ADDRESSES: Mary C. Switzer Building
(330 C Street, SW., Washington, DC
20201), Conference Room 4090. [Please
bring photo ID for entry to a Federal
building.]
FOR FURTHER INFORMATION CONTACT:
https://www.hhs.gov/healthit/ahic/
bio_main.html.
The
meeting will be available via Web cast
at https://www.eventcenterlive.com/
cfmx/ec/logic/login1.cfm?BID=67.
SUPPLEMENTARY INFORMATION:
Dated: August 23, 2006.
Judith Sparrow,
Director, American Health Information
Community, Office of Programs and
Coordination, Office of the National
Coordinator for Health Information
Technology.
[FR Doc. 06–7379 Filed 8–31–06; 8:45 am]
BILLING CODE 4150–24–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the National Coordinator for
Health Information Technology;
American Health Information
Community Biosurveillance Data
Steering Group Meeting
ACTION:
Announcement of meeting.
SUMMARY: This notice announces the
sixth meeting of the American Health
Information Community Biosurveillance
Data Steering Group in accordance with
the Federal Advisory Committee Act
(Pub. L. 92–463, 5 U.S.C., App.).
DATES: September 14, 2006 from 1:30
p.m. to 4:30 p.m.
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
Mary C. Switzer Building
(330 C Street, SW., Washington, DC
20201), Conference Room 4090 (you
will need a photo ID to enter a Federal
building).
FOR FURTHER INFORMATION CONTACT:
https://www.hhs.gov/healthit/ahic/
bio_main.html.
ADDRESSES:
The
meeting will be available via Internet
access. Go to https://www.hhs.gov/
healthit/ahic/bio_instruct.html for
additional information on the meeting.
SUPPLEMENTARY INFORMATION:
Dated: August 25, 2006.
Judith Sparrow,
Director, American Health Information
Community, Office of Programs and
Coordination, Office of the National
Coordinator for Health Information
Technology.
[FR Doc. 06–7380 Filed 8–31–06; 8:45 am]
BILLING CODE 4150–24–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Task Force on Fetal Alcohol
Syndrome and Fetal Alcohol Effect:
Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC), National
Center on Birth Defects and
Developmental Disabilities (NCBDDD)
announces the following meeting.
Name: National Task Force on Fetal
Alcohol Syndrome and Fetal Alcohol
Effect (NTFFASFAE).
Times and Dates: September 26, 2006,
8:30 a.m.–4:30 p.m.; September 27,
2006, 8:30 a.m.–1 p.m.
Place: Doubletree Atlanta Buckhead,
3342 Peachtree Road, NE., Atlanta,
Georgia 30326, telephone 404 231–1234,
fax 404 231–3112.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 80
people.
Purpose: The Secretary is authorized
by the Public Health Service Act,
Section 399G, (42 U.S.C. Section 280f,
as added by Public Law 105–392) to
establish a National Task Force on Fetal
Alcohol Syndrome (FAS) and Fetal
Alcohol Effect (FAE) to: (1) Foster
coordination among all governmental
agencies, academic bodies and
community groups that conduct or
support FAS and FAE research,
programs and surveillance; and (2) to
otherwise meet the general needs of
E:\FR\FM\01SEN1.SGM
01SEN1
Federal Register / Vol. 71, No. 170 / Friday, September 1, 2006 / Notices
populations actually or potentially
impacted by FAS and FAE.
Matters to be Discussed: Agenda items
include: Overview of recent research on
innovative approaches to help in
identification and diagnosis of FAS and
other alcohol-related
neurodevelopmental disorders, update
on Task Force report of evidence-based
review of fetal alcohol spectrum
disorders prevention strategies; updates
from the Interagency Coordinating
Committee on Fetal Alcohol Syndrome,
the CDC and other Federal agencies, and
liaison representatives; and scheduling
of the next meeting. Agenda items are
subject to change as priorities dictate.
For Further Information Contact:
Mary Kate Weber, M.P.H., Designated
Federal Official, National Center on
Birth Defects and Developmental
Disabilities, CDC, 1600 Clifton Road,
NE., (E–86), Atlanta, Georgia 30333,
telephone 404 498–3926, fax 404 498–
3550.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: August 28, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–14556 Filed 8–31–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
sroberts on PROD1PC70 with NOTICES
ICD–9–CM Coordination and
Maintenance Committee Meeting
The National Center for Health
Statistics (NCHS), Classifications and
Public Health Data Standards Staff,
announces the following meeting.
Name: ICD–9–CM Coordination and
Maintenance Committee meeting.
Times and Dates: 9 a.m.–5 p.m.,
September 28–29, 2006.
Place: Centers for Medicare and
Medicaid Services (CMS) Auditorium,
7500 Security Boulevard, Baltimore,
Maryland.
Status: Open to the public.
Purpose: The ICD–9–CM Coordination
and Maintenance (C&M) Committee will
hold its final meeting of the 2006
calendar year cycle on Thursday and
Friday, September 28–29, 2006. The
VerDate Aug<31>2005
16:21 Aug 31, 2006
Jkt 208001
C&M meeting is a public forum for the
presentation of proposed modifications
to the International Classification of
Diseases, Ninth-Revision, Clinical
Modification.
Matters To Be Discussed: Tentative
agenda items include:
Abnormal cytology of vagina,
Acquired absence of cervix/uterus,
Acquired pure red cell aplasia,
Antenatal screening,
Avian (bird) flu,
Disorder/Disease of stomach index
entries,
E code for Fosamax and similar
compounds,
Fetal medicine,
Harmful algae bloom,
Hearing loss and speech language
problems,
History of stroke without residual
deficits/TIA,
Human Parvovirus,
In vitro treatment status,
Malignant ascites,
Myotonic disorders,
Osteonecrosis of jaw, drug induced,
Personal history of sudden cardiac
arrest (cardiac arrhythmia),
Personal history of cervical dysplasia,
Screening for HPV,
Secondary Diabetes Mellitus (updated
proposal),
Septic embolism,
TORCH infections,
Total occlusion of peripheral vessel,
Urinary risk factors,
VIN and VAIN (Continuation),
Addenda (diagnosis),
Blood Brain Barrier,
Coflex interspinous stabilization
device,
Intracranial Pressure (ICP) Monitoring
and Oxygen Monitoring,
Motion Preserving Technologies,
NeuroThera TM: Non-invasive Ischemic
Stroke Therapy,
Pelvic Prolapse Repair,
Rheos Baroreflex Activating System,
Spy intraoperative fluorescence vascular
angiography,
Thoracoscopic procedures,
TOPS TM Facet Replacement,
Addenda (procedures),
ICD–10–PCS.
Contact Person for Additional
Information: Amy Blum, Medical
Systems Specialist, Classifications and
Public Health Data Standards Staff,
NCHS, 3311 Toledo Road, Room 2402,
Hyattsville, Maryland 20782, e-mail
alb8@cdc.gov, telephone 301–458–4106
(diagnosis), Mady Hue, Health
Insurance Specialist, Division of Acute
Care, CMS, 7500 Security Blvd.,
Baltimore, Maryland 21244, e-mail
Marilu.Hue@cms.hhs.gov, telephone
410–786–4510 (procedures).
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
52077
Notice: Because of increased security
requirements CMS has instituted
stringent procedures for entrance into
the building by non-government
employees. Persons without a
government I.D. will need to show an
official form of picture I.D., (such as a
drivers license), and sign-in at the
security desk upon entering the
building. Those who wish to attend a
specific ICD–9–CM C&M meeting in the
CMS auditorium must submit their
name and organization for addition to
the meeting visitor list. Those wishing
to attend the September 28–29, 2006
meeting must submit their name and
organization by September 25, 2006 for
inclusion on the visitor list. This visitor
list will be maintained at the front desk
of the CMS building and used by the
guards to admit visitors to the meeting.
Those who attended previous ICD–9–
CM C&M meetings will no longer be
automatically added to the visitor list.
You must request inclusion of your
name prior to each meeting you attend.
Register to attend the meeting on-line at:
https://cms.hhs.gov/events.
Notice: This is a public meeting.
However, because of fire code
requirements, should the number of
attendants meet the capacity of the
room, the meeting will be closed.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: August 28, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–14557 Filed 8–31–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Health Statistics
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC), National
Center for Health Statistics (NCHS)
announces the following committee
meeting.
Name: Board of Scientific Counselors
(BSC), NCHS.
E:\FR\FM\01SEN1.SGM
01SEN1
Agencies
[Federal Register Volume 71, Number 170 (Friday, September 1, 2006)]
[Notices]
[Pages 52076-52077]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-14556]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol
Effect: Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), National Center on Birth Defects and Developmental
Disabilities (NCBDDD) announces the following meeting.
Name: National Task Force on Fetal Alcohol Syndrome and Fetal
Alcohol Effect (NTFFASFAE).
Times and Dates: September 26, 2006, 8:30 a.m.-4:30 p.m.; September
27, 2006, 8:30 a.m.-1 p.m.
Place: Doubletree Atlanta Buckhead, 3342 Peachtree Road, NE.,
Atlanta, Georgia 30326, telephone 404 231-1234, fax 404 231-3112.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 80 people.
Purpose: The Secretary is authorized by the Public Health Service
Act, Section 399G, (42 U.S.C. Section 280f, as added by Public Law 105-
392) to establish a National Task Force on Fetal Alcohol Syndrome (FAS)
and Fetal Alcohol Effect (FAE) to: (1) Foster coordination among all
governmental agencies, academic bodies and community groups that
conduct or support FAS and FAE research, programs and surveillance; and
(2) to otherwise meet the general needs of
[[Page 52077]]
populations actually or potentially impacted by FAS and FAE.
Matters to be Discussed: Agenda items include: Overview of recent
research on innovative approaches to help in identification and
diagnosis of FAS and other alcohol-related neurodevelopmental
disorders, update on Task Force report of evidence-based review of
fetal alcohol spectrum disorders prevention strategies; updates from
the Interagency Coordinating Committee on Fetal Alcohol Syndrome, the
CDC and other Federal agencies, and liaison representatives; and
scheduling of the next meeting. Agenda items are subject to change as
priorities dictate.
For Further Information Contact: Mary Kate Weber, M.P.H.,
Designated Federal Official, National Center on Birth Defects and
Developmental Disabilities, CDC, 1600 Clifton Road, NE., (E-86),
Atlanta, Georgia 30333, telephone 404 498-3926, fax 404 498-3550.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: August 28, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E6-14556 Filed 8-31-06; 8:45 am]
BILLING CODE 4163-18-P